TransMedics Group Inc vs Global X Uranium ETF — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while Global X Uranium ETF trades at $40.59. Which is the better fit depends on your goals.
| TMDX | URA | |
|---|---|---|
Market Cap | $2.54B | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $150.42 | $61.81 |
52-Week Low | $61.99 | $36.45 |
Enterprise Value | $2.94B | — |
Trailing returns across standard periods
Latest headlines on both assets
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →